InMode (INMD) Other Accumulated Expenses (2018 - 2026)
InMode (INMD) posted quarterly Other Accumulated Expenses of $44.1 million for Q1 2026, up 5.72% year-on-year from $41.7 million in Q1 2025, and up 8.33% on a QoQ basis from $40.7 million in Q4 2025.
InMode (INMD) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Other Accumulated Expenses for 9 consecutive years, with $44.1 million the latest figure, recorded in Q1 2026.
- Quarterly Other Accumulated Expenses rose 5.72% year-over-year to $44.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.1 million (up 5.72% YoY) and the FY2025 annual result came in at $40.7 million, up 3.62% from the prior year.
- Other Accumulated Expenses improved to $44.1 million in Q1 2026 per INMD's latest filing, from $40.7 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for INMD reached as high as $52.0 million in Q4 2022 and fell as low as $23.9 million in Q1 2022.
- A 5-year average of $37.3 million and a median of $38.5 million in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses jumped 77.61% — and 2023, when it dropped 24.5%.
- Year by year, Other Accumulated Expenses stood at $52.0 million in 2022, then declined by 24.5% to $39.2 million in 2023, then climbed by 0.17% to $39.3 million in 2024, then advanced by 3.62% to $40.7 million in 2025, then climbed by 8.33% to $44.1 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $44.1 million, $40.7 million, and $36.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.13 Mn |
| Dec 31, 2025 | 40.74 Mn |
| Sep 30, 2025 | 36.51 Mn |
| Jun 30, 2025 | 36.06 Mn |
| Mar 31, 2025 | 41.75 Mn |
| Dec 31, 2024 | 39.31 Mn |
| Sep 30, 2024 | 44.16 Mn |
| Jun 30, 2024 | 38.53 Mn |
| Mar 31, 2024 | 31.26 Mn |
| Dec 31, 2023 | 39.25 Mn |
| Sep 30, 2023 | 39.23 Mn |
| Jun 30, 2023 | 36.34 Mn |
| Mar 31, 2023 | 30.39 Mn |
| Dec 31, 2022 | 51.98 Mn |
| Sep 30, 2022 | 32.18 Mn |
| Jun 30, 2022 | 28.05 Mn |
| Mar 31, 2022 | 23.95 Mn |
| Dec 31, 2021 | 29.27 Mn |
| Sep 30, 2021 | 32.18 Mn |
| Jun 30, 2021 | 21.12 Mn |